Letermovir use for cytomegalovirus prophylaxis following lung transplantation: A single-center review

Letermovir use for cytomegalovirus prophylaxis following lung transplantation: A single-center review

Background: Cytomegalovirus (CMV) remains a major cause of infection following solid organ transplant and valganciclovir prophylaxis is the standard of care. However, valganciclovir-associated myelosuppression limits its tolerability and can require dose reduction in immunosuppression, particularly...

Full description

Saved in:
Bibliographic Details
Main Authors: Alyssa K. Mezochow, MD, MSc, Kevin D. He, MD, Kathryn Whitaker, MD, Emily Blumberg, MD, Maria M. Crespo, MD, Andrew Courtwright, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:JHLT Open
Subjects:
cytomegalovirus
infection
letermovir
lung transplant
prophylaxis
Online Access:http://www.sciencedirect.com/science/article/pii/S2950133424000983
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items